Related Experiment Videos
Mad-related genes in the human
G J Riggins1, S Thiagalingam, E Rozenblum
1Johns Hopkins Oncology Center, Baltimore, Maryland 21231, USA.
Nature Genetics
|July 1, 1996
Summary
Tumor cells often resist transforming growth factor-beta (TGF-β) signaling. Researchers identified novel human genes related to TGF-β signaling, with mutations found in colorectal cancers, suggesting a role in tumor suppression.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Resistance to transforming growth factor-beta (TGF-β) is a hallmark of human cancers.
- The mechanisms underlying TGF-β resistance in tumors are largely unknown.
- TGF-β signaling pathways are crucial for regulating cell growth and differentiation.
Purpose of the Study:
- To identify novel human genes involved in TGF-β signaling.
- To investigate the potential role of these genes in cancer development and progression.
- To explore the mechanisms of TGF-β resistance in neoplastic cells.
Main Methods:
- Identification of novel human genes homologous to the Drosophila Mad gene.
- Somatic mutation analysis in colorectal cancer samples.
- Chromosomal localization of identified genes.
Main Results:
- Five novel human genes related to the Drosophila Mad gene were identified.
- Somatic mutations in one of these genes were detected in 2 out of 18 colorectal cancers.
- Three of the identified genes were mapped to chromosomal regions previously associated with tumor suppressor activity.
Conclusions:
- The identified gene family plays a significant role in TGF-β signal transduction.
- Mutations and chromosomal alterations in these genes suggest their involvement in tumor suppression.
- This gene family may be critical for mediating the growth inhibitory effects of TGF-β-like ligands and could be important in preventing neoplasia.